Correlation Between Spineguard and Acticor Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spineguard and Acticor Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spineguard and Acticor Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spineguard and Acticor Biotech SAS, you can compare the effects of market volatilities on Spineguard and Acticor Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spineguard with a short position of Acticor Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spineguard and Acticor Biotech.

Diversification Opportunities for Spineguard and Acticor Biotech

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Spineguard and Acticor is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Spineguard and Acticor Biotech SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acticor Biotech SAS and Spineguard is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spineguard are associated (or correlated) with Acticor Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acticor Biotech SAS has no effect on the direction of Spineguard i.e., Spineguard and Acticor Biotech go up and down completely randomly.

Pair Corralation between Spineguard and Acticor Biotech

Assuming the 90 days trading horizon Spineguard is expected to under-perform the Acticor Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Spineguard is 1.66 times less risky than Acticor Biotech. The stock trades about 0.0 of its potential returns per unit of risk. The Acticor Biotech SAS is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  542.00  in Acticor Biotech SAS on September 12, 2024 and sell it today you would lose (517.00) from holding Acticor Biotech SAS or give up 95.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Spineguard  vs.  Acticor Biotech SAS

 Performance 
       Timeline  
Spineguard 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Spineguard are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Spineguard reported solid returns over the last few months and may actually be approaching a breakup point.
Acticor Biotech SAS 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Spineguard and Acticor Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spineguard and Acticor Biotech

The main advantage of trading using opposite Spineguard and Acticor Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spineguard position performs unexpectedly, Acticor Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acticor Biotech will offset losses from the drop in Acticor Biotech's long position.
The idea behind Spineguard and Acticor Biotech SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk